Know Cancer

or
forgot password

Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography


Phase 3
40 Years
85 Years
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography


Objectives: 1) To establish the non-inferiority of the diagnostic accuracy of the Planmed
Sophie Nuance Full Field Digital Mammography (FFDM) X-ray System compared to screen-film
mammography (SFM) in the detection of breast cancer; and 2) To demonstrate in a comparative
side-by-side feature analysis that interpretations based on the Planmed Sophie Nuance FFDM
X-ray System are diagnostically non-inferior to SFM in the detection of breast cancer.


Inclusion Criteria:



1. Subject is 40 years of age or older

2. Subject is presenting for routine breasts cancer screening (Cohort I) OR Subject has
one or both breasts scored 4 or 5 on the BI-RADS scale as a result of SFM either for
routine breast cancer screening or for follow-up or diagnostic mammography (Cohort
II)

3. Subject's schedule permits the SFM and the FFDM to be performed no more than 30 days
apart and with no intervention between the exams

4. Subject will provide prospective, written informed consent

5. Subject is considered capable of complying with study procedures including a
willingness to return for a one-year follow-up exam -

Exclusion Criteria:

1. Subject is pregnant or possibly pregnant or planning pregnancy within the next 15
months

2. Subject has undergone a breast augmentation or breast implant? Has subject had any of
the following breast procedures?

Fine needle or cyst aspiration NOT Eligible if within past year Biopsy Not Eligible
if within past year Lumpectomy (for breast cancer) Mastectomy (for breast cancer)
Radiation therapy Breast reconstruction Breast reduction Not Eligible if within
past year

3. Subject has had an invasive breast procedure or operation within the past year

4. Subject has significant existing breast trauma

5. Subject has a history of breast cancer treated with operation or radiation

6. Subject has any other condition or personal circumstance that, in the judgment of the
investigator, might interfere with the collection of complete good quality data

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Area under ROC curve based on subjects' maximum POM scores; sensitivity based on subjects' maximum BI-RADS scores with 4 or higher as positive for cancer; and specificity based on subjects maximum BI-RADS scores with 4 or higher as positive for cancer

Outcome Time Frame:

Approximately one year after completion of study.

Safety Issue:

No

Principal Investigator

Sami Tohka, PhD

Investigator Role:

Study Director

Investigator Affiliation:

Planmed Oy

Authority:

United States: Institutional Review Board

Study ID:

TK01007

NCT ID:

NCT00942396

Start Date:

April 2008

Completion Date:

March 2011

Related Keywords:

  • Breast Cancer
  • Mammography
  • Breast Neoplasms

Name

Location

Mroz-Baier Breast Care Clinic Memphis, Tennessee  38119
The Rose Houston, Texas  77034